Faslodex 250mg Injection

Faslodex 250mg Injection (Fulvestrant)

Product Description:
Faslodex Injection contains Fulvestrant, an estrogen receptor antagonist used for hormone receptor-positive breast cancer in women, particularly postmenopausal. It blocks and degrades estrogen receptors, preventing growth of estrogen-dependent breast cancer cells. Faslodex is effective in advanced or metastatic cases and in patients resistant to prior hormonal therapies.

Key Features & Benefits

• Contains Fulvestrant 250mg per prefilled syringe

• Used for hormone receptor-positive breast cancer

• Suitable for postmenopausal women with advanced or metastatic disease

• Administered via intramuscular (IM) injection

• Effective in patients resistant to prior hormonal therapies

Indications

• Advanced or metastatic hormone receptor-positive breast cancer

• Disease progression after anti-estrogen therapy (e.g., Tamoxifen)

Dosage & Administration

• Recommended: 500mg IM (two 250mg injections) once a month

• Additional dose at 2 weeks during initiation

• Administered as a slow intramuscular injection in the buttock by a healthcare professional

Storage Instructions

• Store at 2°C – 8°C (Refrigerated)

• Do not freeze; protect from light

• Keep out of reach of children

Packaging

• Prefilled syringe containing Faslodex 250mg Injection

Why Buy Faslodex Injection Online

• 100% authentic & quality-assured oncology medicine

• Affordable Faslodex 250mg price

• Worldwide delivery with temperature-controlled packaging

• Trusted supplier & exporter of breast cancer medicines

Disclaimer:
Faslodex 250mg Injection (Fulvestrant) is prescription-only and must be administered under the supervision of a qualified oncologist.